Calalayer Lotion
Natural health product licensed in Canada
- Other names
- Calananz Lotion, Calnanz Lotion, Dermananz
- Licence holder
- Nanz Pharma
- NPN or DIN-HM
- 80122372
- Status
- Active licence
- Licence date
- 14 December 2022
- Revision date
- 24 February 2026
- Form
- Lotion
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Huile de ricin hydrogénée de PEG-40, Carboxyméthylcellulose de sodium, Glycérine, Parfum, Eau, Phénol, Isopropanol, Citrate de sodium, Bentonite
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Population not specified | minimum: 0.5 years | Not specified | Not specified |
Uses authorised in Canada
Text supplied in English because no French text is available.
Temporarily dries the oozing and weeping and helps relieve minor skin irritation and itching due to poison ivy/oak/sumac.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80122372
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.